Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Discovery | 19 | 2023 | 1056 | 3.030 |
Why?
|
Molecular Probes | 10 | 2023 | 314 | 2.880 |
Why?
|
Endoribonucleases | 8 | 2023 | 226 | 2.660 |
Why?
|
Drug Design | 16 | 2017 | 1058 | 2.060 |
Why?
|
Muscarinic Antagonists | 5 | 2015 | 136 | 1.860 |
Why?
|
Sulfinic Acids | 6 | 2019 | 16 | 1.670 |
Why?
|
Small Molecule Libraries | 7 | 2019 | 722 | 1.470 |
Why?
|
Proteins | 9 | 2023 | 6015 | 1.430 |
Why?
|
Fluorides | 2 | 2023 | 134 | 1.390 |
Why?
|
Reverse Transcriptase Inhibitors | 6 | 2011 | 621 | 1.320 |
Why?
|
Quinazolines | 5 | 2017 | 1355 | 1.210 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 3 | 2015 | 107 | 1.200 |
Why?
|
Click Chemistry | 5 | 2019 | 98 | 1.170 |
Why?
|
Enzyme Inhibitors | 7 | 2019 | 3703 | 1.040 |
Why?
|
Ubiquitin-Protein Ligases | 4 | 2023 | 1873 | 1.040 |
Why?
|
Proteome | 5 | 2023 | 1818 | 1.010 |
Why?
|
Bronchodilator Agents | 3 | 2015 | 506 | 1.010 |
Why?
|
Molecular Targeted Therapy | 6 | 2020 | 2782 | 0.980 |
Why?
|
Protein Kinase Inhibitors | 9 | 2023 | 5594 | 0.970 |
Why?
|
MAP Kinase Kinase Kinases | 2 | 2015 | 256 | 0.840 |
Why?
|
Patents as Topic | 2 | 2015 | 113 | 0.810 |
Why?
|
Tyrosine | 3 | 2016 | 1440 | 0.800 |
Why?
|
Drug Evaluation, Preclinical | 4 | 2019 | 1346 | 0.790 |
Why?
|
Cysteine | 5 | 2023 | 887 | 0.780 |
Why?
|
Structure-Activity Relationship | 15 | 2020 | 3078 | 0.780 |
Why?
|
Imidazoles | 5 | 2011 | 1175 | 0.740 |
Why?
|
Chemistry, Pharmaceutical | 5 | 2017 | 276 | 0.730 |
Why?
|
Proteomics | 6 | 2019 | 3750 | 0.700 |
Why?
|
Janus Kinase 3 | 2 | 2017 | 77 | 0.700 |
Why?
|
Molecular Structure | 15 | 2019 | 1893 | 0.700 |
Why?
|
Down-Regulation | 2 | 2017 | 2910 | 0.700 |
Why?
|
Photoaffinity Labels | 2 | 2021 | 85 | 0.690 |
Why?
|
Polymers | 2 | 2022 | 1610 | 0.670 |
Why?
|
Cell Membrane Permeability | 4 | 2016 | 575 | 0.660 |
Why?
|
CREB-Binding Protein | 2 | 2017 | 148 | 0.650 |
Why?
|
Sulfuric Acids | 1 | 2017 | 36 | 0.600 |
Why?
|
Biological Assay | 1 | 2020 | 631 | 0.590 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2015 | 3146 | 0.590 |
Why?
|
HIV Reverse Transcriptase | 4 | 2011 | 213 | 0.580 |
Why?
|
Protein Processing, Post-Translational | 3 | 2020 | 1953 | 0.570 |
Why?
|
RNA Cap-Binding Proteins | 1 | 2016 | 16 | 0.560 |
Why?
|
Muscular Atrophy, Spinal | 2 | 2017 | 258 | 0.560 |
Why?
|
Phosphotransferases | 1 | 2017 | 306 | 0.550 |
Why?
|
Urea | 2 | 2008 | 438 | 0.540 |
Why?
|
Microsomes, Liver | 4 | 2017 | 176 | 0.530 |
Why?
|
Protein Kinases | 3 | 2018 | 1613 | 0.520 |
Why?
|
Receptor, Muscarinic M3 | 2 | 2015 | 37 | 0.520 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 656 | 0.520 |
Why?
|
Models, Molecular | 13 | 2019 | 5385 | 0.480 |
Why?
|
Fluorescent Dyes | 2 | 2016 | 1915 | 0.470 |
Why?
|
Lysosomes | 1 | 2020 | 911 | 0.470 |
Why?
|
Vaccines, Synthetic | 2 | 2015 | 614 | 0.470 |
Why?
|
Lysine | 2 | 2018 | 990 | 0.470 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1310 | 0.470 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2016 | 412 | 0.460 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 536 | 0.450 |
Why?
|
Pyrroles | 2 | 2017 | 1131 | 0.450 |
Why?
|
Molecular Conformation | 5 | 2018 | 549 | 0.440 |
Why?
|
Serine | 1 | 2017 | 827 | 0.440 |
Why?
|
Temperature | 3 | 2016 | 2195 | 0.440 |
Why?
|
Pyrimidines | 4 | 2019 | 2978 | 0.430 |
Why?
|
Sulfur Compounds | 3 | 2009 | 34 | 0.430 |
Why?
|
Crystallography, X-Ray | 6 | 2017 | 1967 | 0.430 |
Why?
|
Reactive Nitrogen Species | 1 | 2012 | 35 | 0.420 |
Why?
|
Receptors, Glucagon | 1 | 2013 | 90 | 0.420 |
Why?
|
Drug Industry | 2 | 2016 | 781 | 0.420 |
Why?
|
Biology | 1 | 2014 | 289 | 0.410 |
Why?
|
Oligonucleotides | 2 | 2012 | 589 | 0.410 |
Why?
|
Biomarkers, Pharmacological | 1 | 2013 | 159 | 0.410 |
Why?
|
Administration, Inhalation | 3 | 2011 | 1147 | 0.410 |
Why?
|
Amino Acids | 2 | 2021 | 1713 | 0.380 |
Why?
|
Thermodynamics | 2 | 2009 | 593 | 0.370 |
Why?
|
Stereoisomerism | 6 | 2016 | 623 | 0.360 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2011 | 186 | 0.360 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2013 | 358 | 0.350 |
Why?
|
Carbonic Anhydrase II | 1 | 2009 | 22 | 0.350 |
Why?
|
Pharmaceutical Preparations | 2 | 2016 | 1083 | 0.350 |
Why?
|
Adrenergic beta-Agonists | 1 | 2011 | 347 | 0.350 |
Why?
|
Triazoles | 1 | 2015 | 906 | 0.350 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2009 | 91 | 0.330 |
Why?
|
Pyrazoles | 4 | 2017 | 1985 | 0.320 |
Why?
|
Survival of Motor Neuron 2 Protein | 3 | 2017 | 48 | 0.320 |
Why?
|
Rare Diseases | 1 | 2014 | 613 | 0.320 |
Why?
|
Molecular Imaging | 1 | 2015 | 826 | 0.310 |
Why?
|
Phenylenediamines | 1 | 2008 | 87 | 0.310 |
Why?
|
Amides | 1 | 2011 | 450 | 0.310 |
Why?
|
RNA, Messenger | 4 | 2017 | 12738 | 0.310 |
Why?
|
Fluorine | 1 | 2007 | 84 | 0.300 |
Why?
|
Ethers | 1 | 2007 | 73 | 0.300 |
Why?
|
Eukaryotic Cells | 2 | 2020 | 195 | 0.290 |
Why?
|
Indazoles | 1 | 2009 | 293 | 0.290 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2007 | 224 | 0.280 |
Why?
|
Humans | 62 | 2023 | 752341 | 0.280 |
Why?
|
Nitriles | 1 | 2011 | 955 | 0.260 |
Why?
|
Mass Spectrometry | 5 | 2019 | 2176 | 0.260 |
Why?
|
Binding Sites | 8 | 2021 | 6028 | 0.250 |
Why?
|
Drug Delivery Systems | 2 | 2017 | 2213 | 0.250 |
Why?
|
Leukocytes, Mononuclear | 3 | 2017 | 1820 | 0.240 |
Why?
|
Cells, Cultured | 9 | 2019 | 18915 | 0.240 |
Why?
|
Validation Studies as Topic | 2 | 2016 | 163 | 0.240 |
Why?
|
Antiviral Agents | 3 | 2016 | 3032 | 0.230 |
Why?
|
Anti-Inflammatory Agents | 1 | 2013 | 1791 | 0.230 |
Why?
|
Cell Line | 5 | 2022 | 15633 | 0.230 |
Why?
|
Catalytic Domain | 2 | 2017 | 702 | 0.230 |
Why?
|
Anti-HIV Agents | 3 | 2009 | 4443 | 0.220 |
Why?
|
Bronchoconstriction | 2 | 2015 | 139 | 0.220 |
Why?
|
Sulfur | 1 | 2023 | 164 | 0.210 |
Why?
|
Lipids | 3 | 2012 | 3328 | 0.210 |
Why?
|
Animals | 24 | 2020 | 166802 | 0.210 |
Why?
|
Glycoconjugates | 1 | 2002 | 88 | 0.210 |
Why?
|
Adenosine Triphosphate | 3 | 2017 | 1982 | 0.200 |
Why?
|
Sulfhydryl Compounds | 2 | 2015 | 298 | 0.200 |
Why?
|
Glycolipids | 1 | 2002 | 203 | 0.200 |
Why?
|
Chromatography, Affinity | 1 | 2023 | 534 | 0.200 |
Why?
|
Diazonium Compounds | 1 | 2021 | 18 | 0.200 |
Why?
|
Polymerization | 1 | 2022 | 159 | 0.190 |
Why?
|
Hemoglobin A | 1 | 2020 | 84 | 0.190 |
Why?
|
Periodicals as Topic | 1 | 2012 | 1446 | 0.180 |
Why?
|
Protein Binding | 6 | 2017 | 9273 | 0.180 |
Why?
|
Hemoglobin, Sickle | 1 | 2020 | 113 | 0.180 |
Why?
|
Serum Albumin, Bovine | 2 | 2011 | 318 | 0.180 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13553 | 0.170 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 3107 | 0.170 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2008 | 2199 | 0.170 |
Why?
|
Ubiquitination | 2 | 2022 | 1005 | 0.170 |
Why?
|
Guinea Pigs | 2 | 2011 | 1311 | 0.170 |
Why?
|
HEK293 Cells | 3 | 2017 | 4220 | 0.160 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10797 | 0.160 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13165 | 0.160 |
Why?
|
Diphosphonates | 1 | 2002 | 636 | 0.150 |
Why?
|
Isothiocyanates | 1 | 2017 | 48 | 0.150 |
Why?
|
Enzyme Stability | 1 | 2017 | 220 | 0.140 |
Why?
|
Myotonic Dystrophy | 1 | 2017 | 78 | 0.140 |
Why?
|
Benzbromarone | 1 | 2016 | 7 | 0.140 |
Why?
|
E1A-Associated p300 Protein | 1 | 2017 | 123 | 0.140 |
Why?
|
Models, Chemical | 2 | 2008 | 611 | 0.140 |
Why?
|
Janus Kinases | 1 | 2017 | 248 | 0.140 |
Why?
|
Prokaryotic Cells | 1 | 2016 | 49 | 0.140 |
Why?
|
Chromans | 1 | 2016 | 117 | 0.130 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2016 | 113 | 0.130 |
Why?
|
Tritium | 1 | 2016 | 707 | 0.130 |
Why?
|
Shock, Septic | 1 | 2002 | 759 | 0.130 |
Why?
|
Ipratropium | 1 | 2015 | 19 | 0.130 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2016 | 105 | 0.130 |
Why?
|
Inhibitory Concentration 50 | 3 | 2017 | 456 | 0.130 |
Why?
|
RGS Proteins | 1 | 2015 | 75 | 0.130 |
Why?
|
Dogs | 3 | 2017 | 3840 | 0.130 |
Why?
|
Binding, Competitive | 1 | 2017 | 1137 | 0.130 |
Why?
|
Molecular Dynamics Simulation | 2 | 2016 | 419 | 0.130 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1616 | 0.130 |
Why?
|
Nucleotidyltransferases | 1 | 2017 | 235 | 0.130 |
Why?
|
Quinolines | 1 | 2020 | 749 | 0.130 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 249 | 0.130 |
Why?
|
Macrolides | 1 | 2016 | 205 | 0.130 |
Why?
|
Heterocyclic Compounds | 1 | 2016 | 249 | 0.120 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2023 | 1572 | 0.120 |
Why?
|
Cattle | 2 | 2011 | 3848 | 0.120 |
Why?
|
Ligands | 2 | 2022 | 3274 | 0.120 |
Why?
|
Biological Availability | 1 | 2015 | 396 | 0.120 |
Why?
|
Drug Repositioning | 1 | 2017 | 232 | 0.120 |
Why?
|
Protein Array Analysis | 1 | 2016 | 400 | 0.120 |
Why?
|
Catalysis | 1 | 2016 | 774 | 0.120 |
Why?
|
Protein Structure, Tertiary | 3 | 2017 | 3786 | 0.120 |
Why?
|
Arthritis, Experimental | 1 | 2016 | 292 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 21808 | 0.120 |
Why?
|
Sulfonamides | 2 | 2017 | 1963 | 0.120 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5839 | 0.120 |
Why?
|
Maleimides | 1 | 2014 | 112 | 0.120 |
Why?
|
Peptides, Cyclic | 1 | 2016 | 393 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2014 | 28 | 0.120 |
Why?
|
Morpholines | 1 | 2017 | 583 | 0.110 |
Why?
|
Benzothiazoles | 1 | 2015 | 247 | 0.110 |
Why?
|
Aldehydes | 1 | 2015 | 171 | 0.110 |
Why?
|
Antibodies | 3 | 2017 | 2411 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2008 | 3752 | 0.110 |
Why?
|
Ketones | 1 | 2015 | 181 | 0.110 |
Why?
|
Drug Resistance, Viral | 2 | 2009 | 844 | 0.110 |
Why?
|
Haptens | 1 | 2013 | 163 | 0.110 |
Why?
|
Cricetulus | 1 | 2015 | 817 | 0.110 |
Why?
|
Static Electricity | 1 | 2014 | 264 | 0.110 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2015 | 402 | 0.110 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 428 | 0.110 |
Why?
|
Thiazolidinediones | 1 | 2016 | 465 | 0.110 |
Why?
|
Electrons | 1 | 2014 | 264 | 0.110 |
Why?
|
CHO Cells | 1 | 2015 | 1390 | 0.110 |
Why?
|
Gene Library | 1 | 2015 | 1060 | 0.110 |
Why?
|
Interferons | 1 | 2016 | 699 | 0.100 |
Why?
|
Disulfides | 1 | 2014 | 453 | 0.100 |
Why?
|
Half-Life | 2 | 2017 | 648 | 0.100 |
Why?
|
Phenotype | 3 | 2021 | 16439 | 0.100 |
Why?
|
Anemia, Sickle Cell | 1 | 2020 | 1055 | 0.100 |
Why?
|
Azides | 1 | 2012 | 120 | 0.100 |
Why?
|
Rats | 5 | 2017 | 23562 | 0.100 |
Why?
|
Protein Conformation | 3 | 2021 | 3956 | 0.100 |
Why?
|
Molecular Biology | 1 | 2015 | 578 | 0.100 |
Why?
|
Mutation | 5 | 2023 | 29705 | 0.100 |
Why?
|
Histone Deacetylases | 1 | 2016 | 709 | 0.100 |
Why?
|
Immune System | 1 | 2017 | 796 | 0.100 |
Why?
|
Pharmacokinetics | 1 | 2011 | 86 | 0.100 |
Why?
|
Phenylpropanolamine | 1 | 2010 | 15 | 0.090 |
Why?
|
Cresols | 1 | 2010 | 26 | 0.090 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2016 | 774 | 0.090 |
Why?
|
Peptides | 1 | 2023 | 4292 | 0.090 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 811 | 0.090 |
Why?
|
Cyclobutanes | 1 | 2011 | 58 | 0.090 |
Why?
|
Cell Cycle | 1 | 2019 | 2928 | 0.090 |
Why?
|
Caco-2 Cells | 1 | 2011 | 370 | 0.090 |
Why?
|
Hydrogen Bonding | 1 | 2011 | 291 | 0.090 |
Why?
|
Oximes | 1 | 2012 | 309 | 0.090 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 686 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2016 | 4343 | 0.090 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2021 | 1436 | 0.090 |
Why?
|
Interleukin-17 | 1 | 2016 | 885 | 0.090 |
Why?
|
Titrimetry | 1 | 2009 | 35 | 0.090 |
Why?
|
Calorimetry | 1 | 2009 | 128 | 0.090 |
Why?
|
Apolipoproteins B | 1 | 2011 | 385 | 0.090 |
Why?
|
Histamine H2 Antagonists | 1 | 2011 | 164 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2015 | 1248 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2266 | 0.090 |
Why?
|
Luciferases | 1 | 2011 | 717 | 0.090 |
Why?
|
Ulcer | 1 | 2011 | 203 | 0.090 |
Why?
|
Viral Nonstructural Proteins | 1 | 2011 | 224 | 0.080 |
Why?
|
Benzene | 1 | 2009 | 103 | 0.080 |
Why?
|
Chelating Agents | 1 | 2011 | 384 | 0.080 |
Why?
|
Oligopeptides | 1 | 2015 | 1184 | 0.080 |
Why?
|
Oligonucleotides, Antisense | 1 | 2011 | 448 | 0.080 |
Why?
|
Cross-Linking Reagents | 1 | 2012 | 687 | 0.080 |
Why?
|
Piperidines | 1 | 2017 | 1645 | 0.080 |
Why?
|
Peer Review, Research | 1 | 2012 | 340 | 0.080 |
Why?
|
Drug Stability | 1 | 2009 | 290 | 0.080 |
Why?
|
Allosteric Site | 1 | 2008 | 103 | 0.080 |
Why?
|
Nicotine | 1 | 2013 | 676 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1894 | 0.080 |
Why?
|
Alkynes | 1 | 2009 | 313 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2023 | 5163 | 0.080 |
Why?
|
Chromatography, Thin Layer | 1 | 2007 | 215 | 0.080 |
Why?
|
Solutions | 1 | 2008 | 422 | 0.080 |
Why?
|
Molecular Mimicry | 2 | 2013 | 199 | 0.080 |
Why?
|
Antigens | 1 | 2013 | 1439 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2016 | 6509 | 0.070 |
Why?
|
Cyclopropanes | 1 | 2009 | 422 | 0.070 |
Why?
|
Benzoxazines | 1 | 2009 | 309 | 0.070 |
Why?
|
Nucleosides | 1 | 2007 | 130 | 0.070 |
Why?
|
Cell Survival | 1 | 2016 | 5771 | 0.070 |
Why?
|
NF-kappa B | 1 | 2015 | 2471 | 0.070 |
Why?
|
RNA Interference | 1 | 2015 | 2843 | 0.070 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 2214 | 0.070 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2006 | 138 | 0.060 |
Why?
|
Pyridines | 1 | 2017 | 2861 | 0.060 |
Why?
|
Aziridines | 1 | 2005 | 21 | 0.060 |
Why?
|
Trachea | 1 | 2011 | 1081 | 0.060 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 1119 | 0.060 |
Why?
|
Kinetics | 2 | 2014 | 6352 | 0.060 |
Why?
|
Gene Silencing | 1 | 2011 | 1514 | 0.060 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2006 | 191 | 0.060 |
Why?
|
Mice | 8 | 2020 | 80543 | 0.060 |
Why?
|
Vaccines | 1 | 2013 | 829 | 0.060 |
Why?
|
Benzhydryl Compounds | 1 | 2010 | 933 | 0.060 |
Why?
|
Disease Models, Animal | 3 | 2017 | 17958 | 0.060 |
Why?
|
Neprilysin | 1 | 2006 | 464 | 0.060 |
Why?
|
Amines | 1 | 2005 | 279 | 0.050 |
Why?
|
Lipid A | 1 | 2002 | 69 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2006 | 752 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3448 | 0.050 |
Why?
|
HIV | 1 | 2009 | 1579 | 0.050 |
Why?
|
Voltage-Dependent Anion Channel 1 | 1 | 2021 | 34 | 0.050 |
Why?
|
Diazomethane | 1 | 2021 | 36 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13410 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2021 | 2509 | 0.050 |
Why?
|
Models, Biological | 1 | 2017 | 9449 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6482 | 0.040 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17591 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2016 | 3597 | 0.040 |
Why?
|
Biomedical Research | 1 | 2014 | 3379 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7294 | 0.040 |
Why?
|
Sulfoxides | 1 | 2017 | 46 | 0.040 |
Why?
|
Thiadiazoles | 1 | 2017 | 55 | 0.040 |
Why?
|
Hepatocytes | 2 | 2017 | 1224 | 0.040 |
Why?
|
Escherichia coli | 2 | 2016 | 4183 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11883 | 0.040 |
Why?
|
Fluorescence Polarization | 1 | 2017 | 132 | 0.040 |
Why?
|
Oxidation-Reduction | 2 | 2016 | 2192 | 0.040 |
Why?
|
Nucleotides, Cyclic | 1 | 2017 | 84 | 0.040 |
Why?
|
Janus Kinase 1 | 1 | 2016 | 105 | 0.030 |
Why?
|
Substrate Specificity | 2 | 2014 | 1785 | 0.030 |
Why?
|
Trinucleotide Repeats | 1 | 2017 | 257 | 0.030 |
Why?
|
Macrocyclic Compounds | 1 | 2016 | 66 | 0.030 |
Why?
|
Photochemical Processes | 1 | 2016 | 85 | 0.030 |
Why?
|
RNA Precursors | 1 | 2017 | 212 | 0.030 |
Why?
|
Haemophilus influenzae | 1 | 2016 | 172 | 0.030 |
Why?
|
Virus Replication | 2 | 2016 | 2423 | 0.030 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2017 | 247 | 0.030 |
Why?
|
Gram-Positive Bacteria | 1 | 2016 | 178 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2017 | 520 | 0.030 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2016 | 172 | 0.030 |
Why?
|
Rhinovirus | 1 | 2016 | 199 | 0.030 |
Why?
|
Gram-Negative Bacteria | 1 | 2016 | 268 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2017 | 717 | 0.030 |
Why?
|
GRB2 Adaptor Protein | 1 | 2014 | 101 | 0.030 |
Why?
|
Interferon-beta | 1 | 2016 | 340 | 0.030 |
Why?
|
Signal Transduction | 2 | 2015 | 23233 | 0.030 |
Why?
|
Activating Transcription Factor 2 | 1 | 2014 | 45 | 0.030 |
Why?
|
Diphtheria Toxoid | 1 | 2013 | 26 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2012 | 5279 | 0.030 |
Why?
|
Aluminum Hydroxide | 1 | 2013 | 55 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2013 | 6112 | 0.030 |
Why?
|
HIV-1 | 1 | 2011 | 6827 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1047 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2016 | 701 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1615 | 0.030 |
Why?
|
Antibody Affinity | 1 | 2013 | 245 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2017 | 2220 | 0.030 |
Why?
|
RNA Splicing | 1 | 2017 | 911 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2015 | 626 | 0.030 |
Why?
|
Somatostatin | 1 | 2014 | 445 | 0.030 |
Why?
|
Bronchi | 1 | 2016 | 843 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2015 | 592 | 0.030 |
Why?
|
Keratinocytes | 1 | 2016 | 787 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2017 | 1093 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2016 | 1091 | 0.020 |
Why?
|
Th1 Cells | 1 | 2016 | 999 | 0.020 |
Why?
|
Replicon | 1 | 2011 | 34 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2013 | 772 | 0.020 |
Why?
|
Exons | 1 | 2017 | 2383 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2013 | 1060 | 0.020 |
Why?
|
Erythrocytes | 1 | 2020 | 2400 | 0.020 |
Why?
|
HeLa Cells | 1 | 2017 | 3086 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2016 | 1163 | 0.020 |
Why?
|
Species Specificity | 1 | 2015 | 2404 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2016 | 996 | 0.020 |
Why?
|
Vaccination | 1 | 2002 | 3321 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3781 | 0.020 |
Why?
|
Th17 Cells | 1 | 2016 | 775 | 0.020 |
Why?
|
Protein Engineering | 1 | 2013 | 540 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 20843 | 0.020 |
Why?
|
Carbamates | 1 | 2011 | 199 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2017 | 14296 | 0.020 |
Why?
|
Chemical Phenomena | 1 | 2009 | 508 | 0.020 |
Why?
|
Valine | 1 | 2011 | 408 | 0.020 |
Why?
|
Pyrrolidines | 1 | 2011 | 335 | 0.020 |
Why?
|
Oxygen | 1 | 2020 | 4171 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 1 | 2016 | 1255 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5786 | 0.020 |
Why?
|
Gene Targeting | 1 | 2011 | 838 | 0.020 |
Why?
|
Cell Membrane | 1 | 2017 | 3683 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2013 | 1024 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 16736 | 0.020 |
Why?
|
Solubility | 1 | 2009 | 1083 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2011 | 2285 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5838 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1480 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2016 | 3196 | 0.020 |
Why?
|
Immunoconjugates | 1 | 2013 | 865 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5782 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2011 | 2050 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1976 | 0.020 |
Why?
|
HIV Infections | 1 | 2011 | 17006 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 2009 | 1075 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2016 | 3669 | 0.010 |
Why?
|
Solvents | 1 | 2005 | 293 | 0.010 |
Why?
|
Hepacivirus | 1 | 2011 | 1330 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2021 | 11422 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12060 | 0.010 |
Why?
|
Hydrazines | 1 | 2005 | 225 | 0.010 |
Why?
|
Water | 1 | 2009 | 1397 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8315 | 0.010 |
Why?
|
Pain | 1 | 2017 | 4988 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5693 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10358 | 0.010 |
Why?
|
Computational Biology | 1 | 2013 | 3492 | 0.010 |
Why?
|
Rabbits | 1 | 2006 | 4761 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9465 | 0.010 |
Why?
|
Asthma | 1 | 2016 | 6144 | 0.010 |
Why?
|
Smoking | 1 | 2013 | 9029 | 0.010 |
Why?
|
Swine | 1 | 2006 | 5883 | 0.010 |
Why?
|
Kidney | 1 | 2011 | 6983 | 0.010 |
Why?
|
Liver | 1 | 2011 | 7426 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 13900 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 8157 | 0.010 |
Why?
|
Female | 4 | 2017 | 386053 | 0.010 |
Why?
|
Male | 3 | 2017 | 354881 | 0.010 |
Why?
|